Selvita presents at BIO-Europe 2014

Kraków, 06 October 2014 – Selvita will participate in the upcoming BIO-Europe 2014 conference. The event will take place on 03-05 November 2014, in Frankfurt, Germany. Selvita will also hold a presentation during the BIO-Europe event, presenting in the Cancer category.   The presentation will take place on November 5,…

More

Selvita licenses Cresset’s computational tools for SAR analysis and ligand-based design

Krakow, 03 September 2014 – Cresset, innovative provider of computational chemistry software and services, announced on September 02, 2014 in Cambridge, UK, that Selvita S.A. has licensed Cresset’s Forge and Spark. These applications provide extensive capabilities in SAR analysis, ligand-based molecular design and bioisosteric replacement. Read more about the event….

More

Selvita exhibits at the CPhI Worldwide 2014

Krakow, 26 August, 2014 – Selvita will participate in CPhI Worldwide 2014, one of the greatest pharmaceutical events this year. The exhibition will take place on 7 – 9 October 2014, in Paris, France.   Selvita will be located at the stand #1J58, in Hall 1.   CPhI Worldwide 2014,…

More

Selvita and H3 Biomedicine will present at the Drug Discovery USA Congress 2014

Krakow, 26 August 2014 –  Selvita will participate and present at the upcoming Drug Discovery USA Congress, which will be held on 21 – 22 October 2014, in Boston, USA.   Ms Andrea Gerken, MBA, Deputy Director Alliance Manager at H3 BiomedicineSelvita’s together with Pawel Przewiezlikowski, Selvita’s Chief Executive Officer, will deliver…

More

123